Stefanie Sarantopoulos, MD, PhD.
2 clinical trials · Sponsor
◉ Watch Stefanie Sarantopoulos, MD, PhD.
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD (NCT06233110) | Stefanie Sarantopoulos, MD, PhD. | 2025-10-29 |
| Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant (NCT02611063) | Stefanie Sarantopoulos, MD, PhD. | 2016-01-01 |
Track Stefanie Sarantopoulos, MD, PhD. automatically
Every clearance here is in the API, with alerts when new ones post.